Evaluation of omeprazole as a cost‐effective diagnostic test for gastro‐oesophageal reflux disease
Authors:
Open Access
- 1 January 1999
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 13 (1) , 59-66
Abstract
Background: : There is a need for a simple, therapeutic test that is of diagnostic value and can also provide rapid symptom relief in patients who present with classic, mild symptoms suggestive of gastro‐oesophageal reflux disease (GERD), when the diagnosis is based on symptom assessment alone.Aim: : To assess the diagnostic value of a therapeutic trial of omeprazole 40 mg in a dyspeptic population.Methods: : A total of 90 patients with symptoms suggestive of GERD entered the study. Patients underwent endoscopy and ambulatory oesophageal pH monitoring for 18–24 h. Patients then received omeprazole 40 mg o.m. for 2 weeks.Results: : There was a significant correlation between the diagnoses obtained from a trial of omeprazole and the diagnoses obtained from pH monitoring (P < 0.05). There was no significant correlation between the diagnoses obtained from endoscopy and those obtained from pH monitoring. Both omeprazole and endoscopy were compared to pH monitoring as the ‘gold standard’ for the diagnosis of GERD and the cost per correct diagnosis with omeprazole was £47 (95% CI: £40–£59) compared to £480 (95% CI: £396–£608) with endoscopy. There was a complete absence of acid‐related symptoms in the majority (59%) of patients after 3 days of omeprazole 40 mg therapy and, after 2 weeks, 82% of patients had experienced an improvement in overall symptoms ( 1 grade).Conclusions: : We conclude that omeprazole can be used as a clinically effective tool in the initial management of GERD and that it is of diagnostic value in patients who present with typical symptoms, such as heartburn, when the diagnosis is based on symptom assessment alone.Keywords
This publication has 13 references indexed in Scilit:
- Management strategies for gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 1997
- Current practice and future perspectives in the management of gastro-oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 1997
- Gastroesophageal reflux diseaseCurrent Opinion in Gastroenterology, 1997
- Economic Analysis of Alternative Treatments for Persistent Gastro-Oesophageal Reflux DiseaseScandinavian Journal of Gastroenterology, 1994
- Clinical and Economic Factors in the Selection of Drugs for Gastroesophageal Reflux DiseasePharmacoEconomics, 1993
- The oesophagus and chest pain of uncertain causeThe Lancet, 1992
- Asleep on the Job: Sedation and Monitoring during EndoscopyScandinavian Journal of Gastroenterology, 1992
- OmeprazoleDrugs, 1991
- Dyspepsia: Organic Causes and Differential Characteristics from Functional DyspepsiaScandinavian Journal of Gastroenterology, 1991
- Do Esophageal pH Monitoring Data Depend on Recording Equipment and Probes?Journal of Pediatric Gastroenterology and Nutrition, 1990